Opus Genetics, Inc. (($IRD)) announced an update on their ongoing clinical study. Opus Genetics, Inc. is conducting a clinical study titled ‘An ...

Development and validation of a novel circulating tumor cell response stratification criteria for metastatic castration-resistant prostate cancer clinical trials. This is an ASCO Meeting Abstract from ...

- FDA RMAT designation recognizes encouraging early data from Opus’ Phase 1/2 trial in patients with LCA5, an ultra-rare inherited retinal disease RESEARCH TRIANGLE PARK, N.C., May 06, 2025 (GLOBE ...

(MENAFN- GlobeNewsWire - Nasdaq) - FDA RMAT designation recognizes encouraging early data from Opus' Phase 1/2 trial in patients with LCA5, an ultra-rare inherited retinal disease RESEARCH TRIANGLE ...

Texas removes 1.8 million people from health care plan Kristy McNichol Now: Why the 'Family' Star Left Hollywood Behind Major security operation underway at Trump’s golf course in Scotland as police ...

Myriad Genetics and Lumea Inc. partner to integrate molecular diagnostics into Lumea's digital pathology platform, enhancing cancer care efficiency. Myriad Genetics and Lumea Inc. have announced a ...

Genetic sequencing has gone through several advances. A major breakthrough came when scientists began breaking the billions of letters that compose DNA up into relatively small bits of a few hundred ...

SALT LAKE CITY, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced that its Prolaris prostate cancer prognostic ...

Chinchilla’s NB Genetics and ABS have worked together to implant NuEra T14 male sexed embryos into recipient cows, from the ABS development facility in Wisconsin, USA for the first time in Australia.

Kuwait, Kuwait: Advanced Technology Company (ATC), the leading distributor of comprehensive medical equipment and supplies in Kuwait, partnered with Illumina, a global leader in DNA sequencing and ...